Table 4 Frequency MAP DNA detection in IBD patients and controls
Patient cohort (n) | MAP positive (n) | MAP negative (n) |
|---|---|---|
Control cohort (n = 21) | 7 (33%) | 14 (67%) |
IBD patients Germany | Â | Â |
   -CD (n = 10) | 1 (10%) | 9 (90%) |
   -UC (11) | 4 (36%) | 7 (64%) |
IBD patients Norway | Â | Â |
   -CD (n = 4) | 0 (0%) | 4 (100%) |
   -UC (n = 38) | 6 (16%) | 32 (84) |
IBD patients Norway + Germany | Â | Â |
   -CD (n = 14) | 1 (7%) | 13 (93%) |
   -UC (n = 49) | 10 (20%) | 39 (80%) |